PRKAB1 and metabolic dysfunction-associated steatohepatitis: Understanding the complex regulatory mechanisms of AMPK-regulated pathways may increase the opportunity to develop better effective drugs to prevent NAFLD, thereafter decreasing the incidence of further liver diseases such as NASH, fibrosis, and cancer.